Tab Application Banner
  • Users Online: 30
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Biologics and biosimilars in axial spondyloarthritis: Lots of kids on the block!

Castillo-Gallego Concepcion, Michelena Xabier, Marzo-Ortega Helena

Year : 2020| Volume: 15| Issue : 5 | Page no: 64-70

   This article has been cited by
1 Prospective study of patients with inflammatory back pain, clinical characteristics and treatment response in ankylosing spondylitis in two centers of rheumatology in South India
Subramanian Nallasivan, Dhivya Thiyagarajan, Abirami Manivannan
Indian Journal of Rheumatology. 2022; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]
2 Ixekizumab: an IL-17A inhibitor for the treatment for the treatment of axial spondylarthritis
Stephanie R Harrison,Helena Marzo-Ortega
Expert Review of Clinical Immunology. 2021;
[Pubmed]  [Google Scholar] [DOI]


Read this article